Browsing by Author "Connolly, L."
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Item An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol(Elsevier Ltd.) Frizzell, C.; Ndossi, D.; Kalayou, S.; Eriksen, G. S.; Verhaegen, S.; Sørlie, M.; Elliott, C. T.; Ropstad, E.; Connolly, L.Item An in vitro investigation of endocrine disrupting effects of trichothecenes deoxynivalenol (DON), T-2 and HT-2 toxins(Elsevier Ltd.) Ndossi, D. G.; Frizzell, C.; Tremoen, N. H.; Fæste, C.K.; Verhaegen, S.; Dahl, E.; Eriksen, G. S.; Sørlie, M.; Connolly, L.; Ropstad, E.Item An investigation of the endocrine disrupting potential of enniatin B using in vitro bioassays(Elsevier Ltd.) Kalayou, S.; Ndossi, D.; Frizzell, C.; Groseth, P. K.; Connolly, L.; Sørlie, M.; Verhaegen, S.; Ropstad, E.Item An investigation of the endocrine disrupting potential of enniatin B using in vitro bioassays(ELSEVIER) Kalayou, S.; Ndossi, D.; Frizzell, C.; Groseth, P.; Connolly, L.; Sørlie, M.; Verhaegen, S.; Ropstad, E.Item Relative quantification of the proteomic changes associated with the mycotoxin zearalenone in the H295R steroidogenesis model(Elsevier Ltd) Busk, Ø. L.; Ndossi, D.; Verhaegen, S.; Connolly, L.; Eriksen, G.; Ropstad, E.; Sørlie, M.Item Using SILAC proteomics to investigate the effect of the mycotoxin, alternariol, in the human H295R steroidogenesis model(Springer Science+Business Media Dordrecht 2014) Kalayou, S.; Hamre, A. G.; Ndossi, D.; Connolly, L.; Sørlie, M.; Ropstad, E.; Verhaegen, S.